查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1946566

2026年全球性行为感染传染病分子诊断市场报告

Molecular Diagnostics For Sexually Transmitted Diseases Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，性行为感染（STD）分子诊断市场发展迅速，预计将从2025年的36.7亿美元成长到2026年的40.7亿美元，复合年增长率达10.7%。成长要素包括：对传统血清学检测的依赖、自动化PCR系统普及率低、新兴市场对分子诊断的认知度低、性行为感染的日益流行以及人工操作流程和劳动密集型检测方法。

预计未来几年，性行为感染（STD）分子诊断市场将快速成长，到2030年市场规模将达到60.5亿美元，复合年增长率（CAGR）为10.4%。预测期间的成长要素包括：自动化PCR和核酸萃取技术的进步、照护现场分子诊断的普及、发展中地区医疗基础设施的完善、实验室资讯管理系统（LIMS）的日益普及，以及对快速多重诊断检测的研发投入不断增加。预测期内的主要趋势包括：核酸检测方法的日益普及、照护现场分子诊断解决方案的扩展、对快速准确检测性行为感染的需求不断增长、分子诊断与实验室资讯系统的整合，以及自动化PCR和高通量诊断平台的发展。

性行为感染感染（STI）的日益普及预计将在未来几年推动性行为感染分子诊断市场的成长。性行为感染是由细菌、病毒和寄生虫引起的感染疾病，透过性接触传播，主要影响生殖系统和泌尿器官系统。这种日益流行的趋势主要是由于防护措施使用不当，导致性活跃人群中传播疾病。性性行为感染的分子诊断在控制这些感染疾病发挥着至关重要的作用，它能够早期、准确地检测病原体，即使在无症状感染者中也能进行检测，从而支持及时治疗，遏制疾病传播，并改善患者的整体预后。例如，根据英国政府机构英国健康安全局（UKHSA）于2024年6月发布的数据，2023年英格兰将新增401,800例性性行为感染，比2022年的383,789例成长4.7%。因此，性行为感染的上升趋势正在推动性行为感染分子诊断市场的成长。

为了提高诊断的速度、准确性和可及性，该市场的主要企业正致力于技术创新，例如快速照护现场聚合酵素链锁反应(PCR) 设备。这些携带式设备将样本製备、扩增和检测整合于一体，可在传统实验室之外实现高灵敏度的病原体检测。例如，2025 年 3 月，总部位于美国的诊断技术公司 Visby Medical 推出了 Visby Medical 女性性健康检测。这款一次性携带式PCR 设备可在 30 分钟内检测阴道样本中的披衣菌感染、淋病和滴虫病，无需外部设备或低温运输物流。该产品已获准凭处方笺在家使用，是首个获得 FDA 批准可在临床环境之外用于多种性行为感染传染病的分子诊断检测产品，体现了去中心化和可及性检测的发展趋势。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球性行为感染传染病分子诊断市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 核酸检测技术的日益普及
    • 扩展照护现场分子诊断解决方案
    • 对快速且准确的性行为感染传染病（STD）检测的需求日益增长
    • 整合分子诊断与实验室资讯系统
    • 自动化PCR和高通量诊断平台的发展

第五章 终端用户产业市场分析

  • 临床检查室
  • 医院和诊所
  • 诊断服务提供者
  • 研究和学术机构
  • 公共卫生机构

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球性行为感染传染病分子诊断市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球性行为感染传染病分子诊断市场规模、比较及成长率分析
  • 全球性行为感染传染病分子诊断市场表现：规模与成长，2020-2025年
  • 全球性行为感染传染病分子诊断市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 副产品
  • 设备、服务、耗材、软体
  • 透过技术
  • 检查室，就地检验
  • 透过使用
  • 披衣菌感染衣原体 (CT) 或淋病奈瑟菌 (NG) 检测、梅毒检测、淋病检测、单纯疱疹病毒 (HSV) 检测、人类乳突病毒 (HPV) 检测、人类免疫力缺乏病毒 (HIV) 检测、滴虫、脲原体和霉浆菌检测，以及其他用途
  • 按类型细分：设备和服务
  • 分子诊断分析仪、自动化聚合酵素链锁反应系统、核酸萃取设备、诊断服务供应商、维护和校准服务、安装和训练服务
  • 按类型细分：消耗品
  • 去氧核糖核酸萃取试剂盒、核糖核酸萃取试剂盒、聚合酵素链锁反应试剂、核酸探针、对照品和参考标准品、检测酵素和缓衝溶液
  • 按类型细分：软体
  • 数据解读与报告软体、聚合酵素链锁反应工作流程管理软体、实验室资讯管理系统、诊断决策支援软体、品管监控软体

第十章 区域与国家分析

  • 全球性行为感染传染病分子诊断市场：依地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球性行为感染传染病分子诊断市场：国家、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 性行为感染传染病分子诊断市场：竞争格局及市场占有率（2024年）
  • 性行为感染传染病分子诊断市场：公司估值矩阵
  • 性行为感染传染病分子诊断市场：公司概况
    • F. Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Siemens Healthineers AG
    • Illumina Inc.

第37章：其他领先和创新企业

  • Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, QIAGEN NV, Cepheid, Sansure Biotech Inc., OraSure Technologies Inc., Meridian Bioscience, Seegene Inc., Visby Medical Inc., Zeesan Biotech, Binx Health Inc., GCC Biotech, GeneProof, Solone Life Sciences India（P）Ltd.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年性行为感染传染病分子诊断市场：提供新机会的国家
  • 2030年性行为感染传染病分子诊断市场：充满新机会的细分领域
  • 2030年性行为感染传染病分子诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME5MMDST02_G26Q1

Molecular diagnostics for sexually transmitted diseases (STDs) involve methods that detect the genetic material, DNA or RNA of infectious agents to confirm the presence of pathogens. These techniques are highly accurate and sensitive, allowing detection even in asymptomatic cases. By analyzing the molecular structure of pathogens, these diagnostics ensure reliable identification, supporting faster and more precise diagnosis.

The primary product categories for molecular diagnostics of STDs include instruments and services, consumables, and software. Instruments comprise the diagnostic devices and platforms used for pathogen detection, while services cover laboratory testing, sample processing, and interpretation of diagnostic results provided by healthcare or diagnostic companies. These diagnostics employ various technologies, including laboratory-based testing and point-of-care testing, and are used in a range of applications such as testing for chlamydia trachomatis (CT), neisseria gonorrhoeae (NG), syphilis, gonorrhea, herpes simplex virus (HSV), human papillomavirus (HPV), human immunodeficiency virus (HIV), trichomonas, ureaplasma, mycoplasma, and others.

Tariffs have influenced the molecular diagnostics for sexually transmitted diseases market by increasing the cost of imported instruments, PCR reagents, and nucleic acid extraction kits. Laboratory testing and point-of-care testing segments are particularly affected, with regions such as North America and Asia-Pacific facing higher import duties. This has led to increased operational costs for diagnostic laboratories and service providers. On the positive side, tariffs have encouraged local manufacturing, adoption of alternative suppliers, and development of cost-effective diagnostic solutions.

The molecular diagnostics for sexually transmitted diseases market research report is one of a series of new reports from The Business Research Company that provides molecular diagnostics for sexually transmitted diseases market statistics, including molecular diagnostics for sexually transmitted diseases industry global market size, regional shares, competitors with a molecular diagnostics for sexually transmitted diseases market share, detailed molecular diagnostics for sexually transmitted diseases market segments, market trends and opportunities, and any further data you may need to thrive in the molecular diagnostics for sexually transmitted diseases industry. This molecular diagnostics for sexually transmitted diseases market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The molecular diagnostics for sexually transmitted diseases market size has grown rapidly in recent years. It will grow from $3.67 billion in 2025 to $4.07 billion in 2026 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to reliance on conventional serological tests, limited availability of automated pcr systems, low awareness of molecular diagnostics in emerging markets, growing prevalence of sexually transmitted infections, manual workflow and labor-intensive testing.

The molecular diagnostics for sexually transmitted diseases market size is expected to see rapid growth in the next few years. It will grow to $6.05 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to technological advancements in automated pcr and nucleic acid extraction, expansion of point-of-care molecular diagnostics, increasing healthcare infrastructure in developing regions, rising adoption of laboratory information management systems (lims), growing investment in r&d for rapid and multiplexed diagnostic assays. Major trends in the forecast period include increasing adoption of nucleic acid-based testing methods, expansion of point-of-care molecular diagnostic solutions, rising demand for rapid and accurate std detection, integration of molecular diagnostics with laboratory information systems, growth in automated pcr and high-throughput diagnostic platforms.

The increasing prevalence of sexually transmitted infections (STIs) is expected to drive the growth of the molecular diagnostics for sexually transmitted diseases market in the coming years. STIs are infections caused by bacteria, viruses, or parasites that are transmitted through sexual contact, affecting the reproductive and urinary systems. Their rising prevalence is largely attributed to inconsistent use of protection methods, which facilitates easier transmission among sexually active individuals. Molecular diagnostics for STIs play a vital role in managing these infections by enabling early and accurate detection of pathogens, even in asymptomatic cases, thereby supporting timely treatment, reducing disease transmission, and improving overall patient outcomes. For example, in June 2024, the UK Health Security Agency (UKHSA), a UK-based government agency, reported that in 2023 there were 401,800 new STI diagnoses in England, representing a 4.7% increase compared to 383,789 cases in 2022. Consequently, the rising prevalence of sexually transmitted infections is fueling the growth of the molecular diagnostics for sexually transmitted diseases market.

Key companies in this market are focusing on innovations such as rapid point-of-care polymerase chain reaction (PCR) devices to enhance diagnostic speed, accuracy, and accessibility. These portable devices combine sample preparation, amplification, and detection in a single unit, enabling sensitive pathogen detection outside traditional labs. For instance, in March 2025, Visby Medical, a US-based diagnostic technology company, launched the Visby Medical Women's Sexual Health Test. This single-use, handheld PCR device identifies chlamydia, gonorrhea, and trichomoniasis from vaginal samples in 30 minutes without external instrumentation or cold-chain logistics. Authorized for prescription home use, it represents the first FDA-cleared molecular diagnostic test for multiple STIs usable outside clinical settings, reflecting the trend toward decentralized, accessible testing.

In December 2024, OraSure Technologies, a US-based provider of point-of-care and home diagnostic solutions, acquired Sherlock Biosciences. This acquisition expanded OraSure's molecular diagnostics portfolio in sexual health by integrating Sherlock's over-the-counter chlamydia and gonorrhea self-test, which delivers lab-quality results in under 30 minutes using CRISPR- and isothermal amplification-based platforms. Sherlock Biosciences specializes in molecular diagnostics for sexually transmitted infections.

Major companies operating in the molecular diagnostics for sexually transmitted diseases market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Illumina Inc., Hologic Inc., bioMerieux S.A., QuidelOrtho Corporation, QIAGEN N.V., Cepheid, Sansure Biotech Inc., OraSure Technologies Inc., Meridian Bioscience, Seegene Inc., Visby Medical Inc., Zeesan Biotech, Binx Health Inc., GCC Biotech, GeneProof, Solone Life Sciences India (P) Ltd.

North America was the largest region in the molecular diagnostics for sexually transmitted diseases market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics for sexually transmitted diseases market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the molecular diagnostics for sexually transmitted diseases market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The molecular diagnostics for sexually transmitted diseases market consists of revenues earned by entities by providing services such as test development, sample collection, nucleic acid amplification, and point of care diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The molecular diagnostics for sexually transmitted diseases market also includes sales of polymerase chain reaction kits, isothermal nucleic acid amplification kits, clustered regularly interspaced short palindromic repeats-based tests, and instrument-free molecular diagnostic systems. values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Molecular Diagnostics For Sexually Transmitted Diseases Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses molecular diagnostics for sexually transmitted diseases market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for molecular diagnostics for sexually transmitted diseases ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The molecular diagnostics for sexually transmitted diseases market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Instruments And Services; Consumables; Software
  • 2) By Technology: Laboratory Testing; Point-Of-Care Testing
  • 3) By Application: Chlamydia Trachomatis (CT) Or Neisseria Gonorrhoeae (NG) Testing; Syphilis Testing; Gonorrhea Testing; Herpes Simplex Virus (HSV) Testing; Human Papillomavirus (HPV) Testing; Human Immunodeficiency Virus (HIV) Testing; Trichomonas; Ureaplasma And Mycoplasma; Other Applications
  • Subsegments:
  • 1) By Instruments And Services: Molecular Diagnostic Analyzers; Automated Polymerase Chain Reaction Systems; Nucleic Acid Extraction Instruments; Diagnostic Service Providers; Maintenance And Calibration Services; Installation And Training Services
  • 2) By Consumables: Deoxyribonucleic Acid Extraction Kits; Ribonucleic Acid Extraction Kits; Polymerase Chain Reaction Reagents; Nucleic Acid Probes; Control And Reference Standards; Detection Enzymes And Buffers
  • 3) By Software: Data Interpretation And Reporting Software; Polymerase Chain Reaction Workflow Management Software; Laboratory Information Management Systems; Diagnostic Decision Support Software; Quality Control Monitoring Software
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers AG; Illumina Inc.; Hologic Inc.; bioMerieux S.A.; QuidelOrtho Corporation; QIAGEN N.V.; Cepheid; Sansure Biotech Inc.; OraSure Technologies Inc.; Meridian Bioscience; Seegene Inc.; Visby Medical Inc.; Zeesan Biotech; Binx Health Inc.; GCC Biotech; GeneProof; Solone Life Sciences India (P) Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Molecular Diagnostics For Sexually Transmitted Diseases Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Molecular Diagnostics For Sexually Transmitted Diseases Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Molecular Diagnostics For Sexually Transmitted Diseases Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Molecular Diagnostics For Sexually Transmitted Diseases Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Nucleic Acid-Based Testing Methods
    • 4.2.2 Expansion Of Point-Of-Care Molecular Diagnostic Solutions
    • 4.2.3 Rising Demand For Rapid And Accurate Std Detection
    • 4.2.4 Integration Of Molecular Diagnostics With Laboratory Information Systems
    • 4.2.5 Growth In Automated Pcr And High-Throughput Diagnostic Platforms

5. Molecular Diagnostics For Sexually Transmitted Diseases Market Analysis Of End Use Industries

  • 5.1 Clinical Laboratories
  • 5.2 Hospitals And Clinics
  • 5.3 Diagnostic Service Providers
  • 5.4 Research And Academic Institutions
  • 5.5 Public Health Organizations

6. Molecular Diagnostics For Sexually Transmitted Diseases Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Molecular Diagnostics For Sexually Transmitted Diseases Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Molecular Diagnostics For Sexually Transmitted Diseases PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Molecular Diagnostics For Sexually Transmitted Diseases Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Molecular Diagnostics For Sexually Transmitted Diseases Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Molecular Diagnostics For Sexually Transmitted Diseases Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Molecular Diagnostics For Sexually Transmitted Diseases Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Molecular Diagnostics For Sexually Transmitted Diseases Market Segmentation

  • 9.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Instruments And Services, Consumables, Software
  • 9.2. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Laboratory Testing, Point-Of-Care Testing
  • 9.3. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Chlamydia Trachomatis (CT) Or Neisseria Gonorrhoeae (NG) Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus (HSV) Testing, Human Papillomavirus (HPV) Testing, Human Immunodeficiency Virus (HIV) Testing, Trichomonas, Ureaplasma And Mycoplasma, Other Applications
  • 9.4. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Sub-Segmentation Of Instruments And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Molecular Diagnostic Analyzers, Automated Polymerase Chain Reaction Systems, Nucleic Acid Extraction Instruments, Diagnostic Service Providers, Maintenance And Calibration Services, Installation And Training Services
  • 9.5. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Nucleic Acid Probes, Control And Reference Standards, Detection Enzymes And Buffers
  • 9.6. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Data Interpretation And Reporting Software, Polymerase Chain Reaction Workflow Management Software, Laboratory Information Management Systems, Diagnostic Decision Support Software, Quality Control Monitoring Software

10. Molecular Diagnostics For Sexually Transmitted Diseases Market Regional And Country Analysis

  • 10.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 11.1. Asia-Pacific Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 12.1. China Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 13.1. India Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 14.1. Japan Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 15.1. Australia Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 16.1. Indonesia Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 17.1. South Korea Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 18.1. Taiwan Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 19.1. South East Asia Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 20.1. Western Europe Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 21.1. UK Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 22.1. Germany Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 23.1. France Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 24.1. Italy Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 25.1. Spain Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 26.1. Eastern Europe Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 27.1. Russia Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 28.1. North America Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 29.1. USA Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 30.1. Canada Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 31.1. South America Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 32.1. Brazil Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 33.1. Middle East Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Molecular Diagnostics For Sexually Transmitted Diseases Market

  • 34.1. Africa Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Molecular Diagnostics For Sexually Transmitted Diseases Market Regulatory and Investment Landscape

36. Molecular Diagnostics For Sexually Transmitted Diseases Market Competitive Landscape And Company Profiles

  • 36.1. Molecular Diagnostics For Sexually Transmitted Diseases Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Molecular Diagnostics For Sexually Transmitted Diseases Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Molecular Diagnostics For Sexually Transmitted Diseases Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Molecular Diagnostics For Sexually Transmitted Diseases Market Other Major And Innovative Companies

  • Hologic Inc., bioMerieux S.A., QuidelOrtho Corporation, QIAGEN N.V., Cepheid, Sansure Biotech Inc., OraSure Technologies Inc., Meridian Bioscience, Seegene Inc., Visby Medical Inc., Zeesan Biotech, Binx Health Inc., GCC Biotech, GeneProof, Solone Life Sciences India (P) Ltd.

38. Global Molecular Diagnostics For Sexually Transmitted Diseases Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Molecular Diagnostics For Sexually Transmitted Diseases Market

40. Molecular Diagnostics For Sexually Transmitted Diseases Market High Potential Countries, Segments and Strategies

  • 40.1 Molecular Diagnostics For Sexually Transmitted Diseases Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Molecular Diagnostics For Sexually Transmitted Diseases Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Molecular Diagnostics For Sexually Transmitted Diseases Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer